$ADTX

Aditxt (ADTX) Stock Sinks 20% After-Hours: Here’s What’s Going On - Aditxt (NASDAQ:ADTX)

Aditxt Inc. (NASDAQ:ADTX) shares fell about 20% in after-hours after Nasdaq’s Hearings Panel denied the company’s request to keep its listing, according to an 8-K filing. Nasdaq said trading will be suspended at the open on June 25. Nasdaq cited prior noncompliance, including bid price below $1 and stockholders’ equity of negative $35.17 million.

Original reporting
Published Jun 25, 2026, 6:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 25, 2026, 7:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefRegulation
Primary signal
$ADTX
Bearish
high confidence
Mentioned
$ADTX
Relevance
9/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$ADTXBearishHigh
01

Why it matters

The Hearings Panel denial removes the temporary protection from delisting and sets a concrete suspension date, increasing near-term downside and reducing liquidity for holders and traders.

02

Market read

A concrete Nasdaq listing denial with an imminent trading suspension is a time-sensitive catalyst for ADTX positioning and risk management.

03

What to watch

The article doesn’t cover whether ADTX has a credible path to regain compliance or what venue (if any) trading may migrate to after suspension, which can materially change post-suspension dynamics.

Relevance 9/10Novelty 8/10Timing: ahead of the June 25 open when Nasdaq will suspend ADTX trading

Background

Nasdaq previously flagged non-compliance after ADTX traded below $1 for 30 consecutive business days and failed the $2.5M minimum stockholders’ equity requirement; multiple reverse splits exceeded a 250-to-1 cumulative ratio.

Company-level read

Ticker impact

$ADTXBearishHigh confidence
Context

Nasdaq Hearings Panel denied Aditxt’s request to maintain listing, and trading will be suspended at the open June 25.

Expected impact

High likelihood of continued heavy selling/illiquidity into the June 25 suspension; post-suspension pricing may become erratic or move to alternative venues.

Evidence & confidence

The article cites an 8-K and specifies the suspension timing (open of trading June 25) following denial of the listing appeal.

Market effects

Microcap listing-compliance risk remains elevated; could pressure sentiment toward other Nasdaq-listed small caps with sub-$1 bid and equity shortfalls.

Primarily US microcap liquidity and Nasdaq listing ecosystem impact.

Limited; mostly affects US trading venues and counterparties for this issuer.

Counterpoint

ADTX could still pursue a review with Nasdaq’s Listing and Hearing Review Council, potentially delaying final outcomes and creating short-term trading volatility.

Key entities

  • Aditxt Inc.

    Nasdaq-listed issuer whose listing appeal was denied and whose trading will be suspended June 25.

  • Nasdaq Hearings Panel

    Denied Aditxt’s request to maintain its listing.

  • Nasdaq Listing and Hearing Review Council

    Review body Aditxt may request within 15 days.

Related articles

$ADTXMedAI 8/10

Aditxt (ADTX) Stock Surges Nearly 17% After Hours: Here's Why - Aditxt (NASDAQ:ADTX)

Aditxt (ADTX) shares rose 29.73% during the regular session and gained 16.92% to $0.015 in after-hours, after closing at $0.013, according to Benzinga Pro. The move followed an SEC filing from HRT Financial LP showing it re-accumulated 725,330 shares at $0.019. The company also said its Ignite Proteomics unit is valued at about $150 million in a planned separation.